Your provider should also review your personal or family history, including any family history of thyroid cancer, kidney disease, heart disease, heart failure, diabetic retinopathy, or other conditions that may affect treatment decisions
Manufacturers may expect significant levels of competition, specifically within the GLP-1 RA class, and will need to differentiate their assets and value proposition to remain competitive and maintain and/or grow their market share
Cottage cheese deserves special mention for GLP-1 users
This framing supports the case for continued access to GLP-1 medications even after patients achieve their target weight, which relates to concerns about semaglutide withdrawal symptoms and weight regain after stopping treatment
David Lau, a professor emeritus of medicine, biochemistry and molecular biology at the University of Calgary, is intrigued by this strategy as well